Total Payments
$52,261
2024 Payments
$161.09
Companies
13
Transactions
72
Medicare Patients
639
Medicare Billing
$133,726
Payment Breakdown by Category
Other$22,560 (43.2%)
Consulting$18,350 (35.1%)
Travel$4,975 (9.5%)
Research$4,600 (8.8%)
Food & Beverage$1,690 (3.2%)
Education$85.54 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20,460 | 6 | 39.2% |
| Consulting Fee | $18,350 | 9 | 35.1% |
| Travel and Lodging | $4,975 | 22 | 9.5% |
| Unspecified | $4,600 | 2 | 8.8% |
| Honoraria | $2,100 | 1 | 4.0% |
| Food and Beverage | $1,690 | 25 | 3.2% |
| Education | $85.54 | 7 | 0.2% |
Payments by Type
General
$47,661
70 transactions
Research
$4,600
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Exelixis Inc. | $20,686 | 34 | $0 (2021) |
| PFIZER INC. | $10,745 | 10 | $0 (2024) |
| Janssen Biotech, Inc. | $4,664 | 6 | $0 (2019) |
| Genentech USA, Inc. | $4,208 | 7 | $0 (2019) |
| Daiichi Sankyo Inc. | $3,750 | 2 | $0 (2021) |
| AVEO Pharmaceuticals, Inc. | $2,158 | 2 | $0 (2022) |
| EISAI INC. | $2,025 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $1,500 | 1 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $1,370 | 1 | $0 (2020) |
| Aadi Bioscience, Inc. | $500.00 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $161.09 | 3 | SpringWorks Therapeutics, Inc. ($125.00) |
| 2023 | $27.01 | 2 | Merck Sharp & Dohme LLC ($19.81) |
| 2022 | $558.39 | 2 | Aadi Bioscience, Inc. ($500.00) |
| 2021 | $10,910 | 18 | Exelixis Inc. ($5,050) |
| 2020 | $7,470 | 4 | PFIZER INC. ($4,600) |
| 2019 | $8,215 | 9 | Janssen Biotech, Inc. ($4,664) |
| 2018 | $5,097 | 7 | PFIZER INTERNATIONAL LLC ($4,720) |
| 2017 | $19,821 | 27 | Exelixis Inc. ($15,637) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Merck Sharp & Dohme LLC | WELIREG (Drug) | Education | In-kind items and services | $18.09 | General |
| Category: ONCOLOGY | ||||||
| 04/05/2024 | PFIZER INC. | INLYTA (Drug) | Education | In-kind items and services | $18.00 | General |
| Category: ONCOLOGY | ||||||
| 02/07/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DESMOID TUMORS | ||||||
| 07/06/2023 | PFIZER INC. | INLYTA (Drug) | Education | In-kind items and services | $7.20 | General |
| Category: ONCOLOGY | ||||||
| 04/10/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Education | In-kind items and services | $19.81 | General |
| Category: ONCOLOGY | ||||||
| 12/21/2022 | Aadi Bioscience, Inc. | FYARRO (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: IMMUNOSUPPRESSANT | ||||||
| 06/04/2022 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $58.39 | General |
| Category: Oncology | ||||||
| 12/09/2021 | Exelixis Inc. | CABOMETYX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,960.00 | General |
| Category: Oncology | ||||||
| 11/19/2021 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $190.25 | General |
| Category: Oncology | ||||||
| 11/19/2021 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | Cash or cash equivalent | $29.95 | General |
| Category: Oncology | ||||||
| 11/18/2021 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $65.63 | General |
| Category: Oncology | ||||||
| 11/18/2021 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Oncology | ||||||
| 11/18/2021 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Oncology | ||||||
| 11/18/2021 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Oncology | ||||||
| 11/18/2021 | Exelixis Inc. | CABOMETYX (Drug) | Education | In-kind items and services | $9.57 | General |
| Category: Oncology | ||||||
| 11/17/2021 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $300.15 | General |
| Category: Oncology | ||||||
| 11/17/2021 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $155.00 | General |
| Category: Oncology | ||||||
| 11/17/2021 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $145.00 | General |
| Category: Oncology | ||||||
| 11/17/2021 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $65.00 | General |
| Category: Oncology | ||||||
| 11/17/2021 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | Cash or cash equivalent | $32.73 | General |
| Category: Oncology | ||||||
| 11/17/2021 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | Cash or cash equivalent | $14.34 | General |
| Category: Oncology | ||||||
| 10/21/2021 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Honoraria | Cash or cash equivalent | $2,100.00 | General |
| Category: Oncology | ||||||
| 09/17/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Education | In-kind items and services | $10.87 | General |
| Category: ONCOLOGY | ||||||
| 03/16/2021 | Daiichi Sankyo Inc. | Turalio (Drug) | Consulting Fee | Cash or cash equivalent | $1,875.00 | General |
| Category: ONCOLOGY | ||||||
| 03/16/2021 | Daiichi Sankyo Inc. | Turalio (Drug) | Consulting Fee | Cash or cash equivalent | $1,875.00 | General |
| Category: ONCOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| AXITINIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $4,600 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 128 | 240 | $81,474 | $20,495 |
| 2022 | 7 | 180 | 358 | $106,759 | $34,666 |
| 2021 | 4 | 150 | 328 | $80,631 | $37,702 |
| 2020 | 7 | 181 | 386 | $90,273 | $40,863 |
Total Patients
639
Total Services
1,312
Medicare Billing
$133,726
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 70 | 149 | $42,054 | $10,267 | 24.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 44 | 77 | $32,214 | $8,211 | 25.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $7,206 | $2,016 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 74 | 185 | $48,695 | $13,263 | 27.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 36 | 61 | $23,332 | $6,925 | 29.7% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Facility | 2022 | 11 | 34 | $5,440 | $5,432 | 99.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 22 | 22 | $10,784 | $3,244 | 30.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 31 | $7,812 | $2,453 | 31.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 13 | $6,372 | $2,053 | 32.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $4,324 | $1,296 | 30.0% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Facility | 2021 | 24 | 109 | $17,440 | $17,467 | 100.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 65 | 124 | $28,420 | $8,575 | 30.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 35 | 69 | $23,073 | $8,180 | 35.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 26 | 26 | $11,698 | $3,479 | 29.7% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Facility | 2020 | 19 | 113 | $18,080 | $18,192 | 100.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 67 | 137 | $28,127 | $8,270 | 29.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 29 | 56 | $16,162 | $5,164 | 32.0% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 21 | 21 | $9,170 | $2,886 | 31.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 16 | 16 | $7,768 | $2,685 | 34.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 17 | 31 | $7,750 | $2,549 | 32.9% |
| 99358 | Prolonged patient service without direct patient contact first hour | Office | 2020 | 12 | 12 | $3,216 | $1,116 | 34.7% |
About Dr. Christopher Ryan, MD
Dr. Christopher Ryan, MD is a Medical Oncology healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033127584.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Ryan, MD has received a total of $52,261 in payments from pharmaceutical and medical device companies, with $161.09 received in 2024. These payments were reported across 72 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($20,460).
As a Medicare-enrolled provider, Ryan has provided services to 639 Medicare beneficiaries, totaling 1,312 services with total Medicare billing of $133,726. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical Oncology
- Location Portland, OR
- Active Since 08/03/2006
- Last Updated 09/18/2017
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1033127584
Products in Payments
- Cabometyx (Drug) $11,437
- INLYTA (Drug) $7,925
- CABOMETYX (Drug) $5,050
- Balversa (Drug) $4,664
- TECENTRIQ (Biological) $4,184
- Turalio (Drug) $3,750
- FOTIVDA (Drug) $2,158
- Lenvima (Drug) $2,025
- OPDIVO (Biological) $1,500
- IMFINZI (Drug) $1,370
- FYARRO (Drug) $500.00
- SUTENT (Drug) $298.52
- Avastin (Biological) $126.78
- OGSIVEO (Drug) $125.00
- KEYTRUDA (Biological) $30.68
- WELIREG (Drug) $18.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Portland
Matthew Taylor, Md, MD
Medical Oncology — Payments: $325,133
Medical Oncology $325,133
David Page, M.d, M.D
Medical Oncology — Payments: $236,791
Medical Oncology $236,791
Tomasz Beer, Md, MD
Medical Oncology — Payments: $179,452
Medical Oncology $179,452
Alison Conlin, Md, MD
Medical Oncology — Payments: $86,283
Medical Oncology $86,283
Brendan Curti, Md, MD
Medical Oncology — Payments: $66,023
Medical Oncology $66,023
Dr. Jason Taylor, Md, Phd, MD, PHD
Medical Oncology — Payments: $42,506
Medical Oncology $42,506